What is MBX Biosciences, Inc.'s stock issuance proceeds?

MBX Biosciences, Inc. (MBX) reported stock issuance proceeds of $2.44M in Q1 2026.

How has MBX Biosciences, Inc.'s stock issuance proceeds changed year-over-year?

MBX Biosciences, Inc.'s stock issuance proceeds increased by 60950.0% year-over-year, from $4K to $2.44M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

MBX Biosciences, Inc. MBX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Viking TherapeuticsVKTX

$450K+28.9%

BridgeBio PharmaBBIO

$22.59M—

Nurix Therapeutics, Inc.NRIX

$18M—

Crinetics PharmaceuticalsCRNX

$380.51M—

XER

Xeris Biopharma Holdings, Inc.XERS

$847K-82.6%

Xenon PharmaceuticalsXENE

$5.49M+377%

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.3B+475%

Enterprise value$2.26B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s stock issuance proceeds?: MBX Biosciences, Inc. (MBX) reported stock issuance proceeds of $2.44M in Q1 2026.
How has MBX Biosciences, Inc.'s stock issuance proceeds changed year-over-year?: MBX Biosciences, Inc.'s stock issuance proceeds increased by 60950.0% year-over-year, from $4K to $2.44M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.